Table of Contents Table of Contents
Previous Page  342 / 596 Next Page
Information
Show Menu
Previous Page 342 / 596 Next Page
Page Background

4

Receipt Confirmation form provided and fax or email it back to the study director.The shipment

1

and hold timesof the inoculated test material had been verified as a quality control measure prior

2

to study initiation.

3

4

Test Portion Analysis

5

6

Collaborators were instructed to follow the appropriate preparation and analysis as outlined in

7

the study protocol for each matrix for both the 3M MDA 2 -

Listeria

method and reference

8

method. For both matrices, each collaborator received 72 test portions (12 high, 12 low and 12

9

un-inoculated controls for each method to be performed). For the analysis of the deli turkey test

10

portions by the 3M MDA 2 -

Listeria

method, a 125 g portion was enriched with 975 mL of

11

Demi-Fraser (DF) broth, homogenized for 2 minutes and incubated for 24-28 hours at 37 ±1

o

C.

12

For the raw chicken breast fillettest portions analyzed by the 3M MDA 2 -

Listeria

method, a 25

13

g portion was enriched with 475 mL of DF, homogenized for 2 minutes and incubated for 28-32

14

hours at 37 ±1

o

C.

15

Following enrichment, samples were assayed by the 3M MDA 2 -

Listeria

method and,

16

regardless of presumptive result, confirmed following the USDA/FSIS MLG 8.09 reference

17

method. Both matrices evaluated by the 3M MDA 2 -

Listeria

method were compared to

18

samples analyzed using the USDA/FSIS MLG 8.09 reference method in an unpaired study

19

design. All positive test portions were biochemically confirmed by the API

Listeria

biochemical

20

test or by the VITEK 2 GPbiochemical identification test, AOAC Official Method 2012.02 [8].

21

22

Statistical Analysis

23

24

Each collaborating laboratory recorded results for the reference method and the 3M MDA 2 -

25

Listeria

method on the data sheets provided. The data sheets were submitted to the study director

26

at the end of each week of testing for statistical analysis. Data for each matrix was analyzed

27

using the probability of detection (POD)statistical model [9]

.

.

POD statistical analysis was

28

conducted using AOAC Binary Data Interlaboratory Study Workbook, Version 2.3 [10].

The

29

probability of detection (POD) was calculated as the number of positive outcomes divided by the

30

total number of trials. The POD was calculated for the candidate presumptive results, POD

CP,

the

31

candidate confirmatory results (

excluding those with presumptive negative resultsincluding false

32

negative results

), POD

CC

, the difference in the candidate presumptive and confirmatory results,

33

dLPOD

CP,

presumptive candidate results that confirmed positive (

(including those with

34

presumptive negative results)excluding false negative results)

, POD

C,

the reference method,

35

POD

R

, and the difference in the confirmed candidate and reference methods, dLPOD

C

. A

36

dLPOD

C

confidence interval not containing the point zero would indicate a statistically

37

significant difference between the 3M MDA 2 -

Listeria

and the reference methods at the 5 %

38

probability level. In addition to POD, the repeatability standard deviation (s

r

), the among

39

laboratory repeatability standard deviation (s

L

), the reproducibility standard deviation (s

R

)and the

40

P

T

value were calculated. The s

r

provides the

variance variability

of data within one laboratory,

41

the s

L

provides the difference in standard deviation between laboratories and the s

R

provides the

42

variance variability

in data between different laboratories. The P

T

value provides information on

43

the homogeneity test of laboratory PODs

[10]

.

44

45

46

47

48

49